Hospitals are allocating more of their budgets toward new cancer and migraine treatments amid ongoing concerns over prescription drug prices, according to a STAT report.
According to the report, Lumere discovered the trend after analyzing data collected from 26 facilities across four health systems.
To read the full report on STAT, click here.
